BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Prognosis
16 results:

  • 1. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
    Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
    Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Dual-branch hybrid encoding embedded network for histopathology image classification.
    Li M; Hu Z; Qiu S; Zhou C; Weng J; Dong Q; Sheng X; Ren N; Zhou M
    Phys Med Biol; 2023 Sep; 68(19):. PubMed ID: 37647919
    [No Abstract]    [Full Text] [Related]  

  • 3. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
    Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
    Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study.
    Li J; Huang L; Liao C; Liu G; Tian Y; Chen S
    BMC Cancer; 2023 Jun; 23(1):529. PubMed ID: 37296397
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes.
    Li CY; Rajapakshe KI; Maitra A
    Pancreatology; 2022 Nov; 22(7):965-972. PubMed ID: 36008214
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network.
    Mammarella E; Zampieri C; Panatta E; Melino G; Amelio I
    Biol Direct; 2021 Aug; 16(1):11. PubMed ID: 34348766
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Liver Metastasis-Directed Ablative Radiotherapy in pancreatic cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients: Data From a Multi-institutional Retrospective Study.
    Lee G; Kim DW; Oladeru OT; Niemierko A; Gergelis KR; Haddock MG; Toesca DAS; Koong AJ; Owen D; Weekes C; Hong TS; Chang DT; Hallemeier CL; Wo JY
    Pancreas; 2021 May-Jun 01; 50(5):736-743. PubMed ID: 34016893
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma.
    Yu Y; Wang Z; Mo DH; Wang Z; Li G
    Math Biosci Eng; 2021 Feb; 18(2):1708-1721. PubMed ID: 33757206
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting tp63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Adenosquamous Carcinoma of the Pancreas Comprise a Heterogeneous Group of Tumors With the Worst Outcome: A Clinicopathological Analysis of 25 Cases Identified in 562 pancreatic Carcinomas Resected With Curative Intent.
    Boecker J; Feyerabend B; Tiemann K; Buchwalow I; Wagner KC; Oldhafer KJ; Andruszkow J; Daniels T; Boessow D; Boecker W; Neumann UP
    Pancreas; 2020; 49(5):683-691. PubMed ID: 32433407
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer.
    Watanabe K; Mitsunaga S; Kojima M; Suzuki H; Irisawa A; Takahashi H; Sasaki M; Hashimoto Y; Imaoka H; Ohno I; Ikeda M; Akimoto T; Ochiai A
    Cancer Med; 2020 May; 9(9):3130-3141. PubMed ID: 32135041
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrated Genomic and Immunophenotypic Classification of pancreatic cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.
    Wartenberg M; Cibin S; Zlobec I; Vassella E; Eppenberger-Castori S; Terracciano L; Eichmann MD; Worni M; Gloor B; Perren A; Karamitopoulou E
    Clin Cancer Res; 2018 Sep; 24(18):4444-4454. PubMed ID: 29661773
    [No Abstract]    [Full Text] [Related]  

  • 13. The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases.
    Han X; Zhang C; Tang M; Xu X; Liu L; Ji Y; Pan B; Lou W
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):527-35. PubMed ID: 25822862
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Undifferentiated (anaplastic) carcinoma of the pancreas with osteoclast-like giant cells showing various degree of pancreas duct involvement. A case report and literature review.
    Maksymov V; Khalifa MA; Bussey A; Carter B; Hogan M
    JOP; 2011 Mar; 12(2):170-6. PubMed ID: 21386647
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metastatic leiomyosarcoma in the oral cavity: case report with protein expression profiles.
    Kim SM; Myoung H; Choung PH; Kim MJ; Lee SK; Lee JH
    J Craniomaxillofac Surg; 2009 Dec; 37(8):454-60. PubMed ID: 19664933
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Natural history of neuroendocrine enteropancreatic tumors.
    Mignon M
    Digestion; 2000; 62 Suppl 1():51-8. PubMed ID: 10940688
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.